Recombinant multi-species MTH1/NUDT1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine MTH1/NUDT1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
Misincorporation of oxidized nucleoside triphosphates into DNA/RNA during replication and transcription can cause mutations that may result in carcinogenesis or neurodegeneration. The protein encoded by this gene is an enzyme that hydrolyzes oxidized purine nucleoside triphosphates, such as 8-oxo-dGTP, 8-oxo-dATP, 2-hydroxy-dATP, and 2-hydroxy rATP, to monophosphates, thereby preventing misincorporation. The encoded protein is localized mainly in the cytoplasm, with some in the mitochondria, suggesting that it is involved in the sanitization of nucleotide pools both for nuclear and mitochondrial genomes. Several alternatively spliced transcript variants, some of which encode distinct isoforms, have been identified. Additional variants have been observed, but their full-length natures have not been determined. A rare single-nucleotide polymorphism that results in the production of an additional, longer isoform (p26) has been described. [provided by RefSeq, Dec 2018]
The Alternative Names of target: 2-hydroxy-dATP diphosphatase,7,8-dihydro-8-oxoguanine triphosphatase,8-oxo-dGTPase,MTH1,Methylated purine nucleoside triphosphate hydrolase,Mth1,NUDT1,Nucleoside diphosphate-linked moiety X motif 1 (Nudix motif 1),Nudt1,Oxidized purine nucleoside triphosphate hydrolase
Go
to MTH1/NUDT1 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-IP8989-Ag-1/ GM-Tg-hg-IP8989-Ag-2 | Human MTH1/NUDT1 protein | Human |
| GM-Tg-rg-IP8989-Ag-1/ GM-Tg-rg-IP8989-Ag-2 | Rat MTH1/NUDT1 protein | Rat |
| GM-Tg-mg-IP8989-Ag-1/ GM-Tg-mg-IP8989-Ag-2 | Mouse MTH1/NUDT1 protein | Mouse |
| GM-Tg-cynog-IP8989-Ag-1/ GM-Tg-cynog-IP8989-Ag-2 | Cynomolgus/Rhesus macaque MTH1/NUDT1 protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-IP8989-Ag-1/ GM-Tg-felg-IP8989-Ag-2 | Feline MTH1/NUDT1 protein | Feline |
| GM-Tg-cang-IP8989-Ag-1/ GM-Tg-cang-IP8989-Ag-2 | Canine MTH1/NUDT1 protein | Canine |
| GM-Tg-bovg-IP8989-Ag-1/ GM-Tg-bovg-IP8989-Ag-2 | Bovine MTH1/NUDT1 protein | Bovine |
| GM-Tg-equg-IP8989-Ag-1/ GM-Tg-equg-IP8989-Ag-2 | Equine MTH1/NUDT1 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-IP8989-Ag-1/ GM-Tg-hg-IP8989-Ag-2;
GM-Tg-rg-IP8989-Ag-1/ GM-Tg-rg-IP8989-Ag-2;
GM-Tg-mg-IP8989-Ag-1/ GM-Tg-mg-IP8989-Ag-2; GM-Tg-cynog-IP8989-Ag-1/ GM-Tg-cynog-IP8989-Ag-2; GM-Tg-felg-IP8989-Ag-1/ GM-Tg-felg-IP8989-Ag-2; GM-Tg-cang-IP8989-Ag-1/ GM-Tg-cang-IP8989-Ag-2; GM-Tg-bovg-IP8989-Ag-1/ GM-Tg-bovg-IP8989-Ag-2; GM-Tg-equg-IP8989-Ag-1/ GM-Tg-equg-IP8989-Ag-2 |
| Products Name | MTH1/NUDT1 protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | MTH1/NUDT1 |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine MTH1/NUDT1 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.